QQQ   354.84 (-0.02%)
AAPL   179.21 (-0.21%)
MSFT   333.68 (-0.67%)
META   271.12 (-0.10%)
GOOGL   127.31 (+1.03%)
AMZN   126.61 (+1.05%)
TSLA   221.31 (+1.70%)
NVDA   386.54 (-1.32%)
NIO   7.87 (+2.61%)
BABA   86.69 (+2.71%)
AMD   124.23 (+5.34%)
T   15.66 (+1.75%)
F   12.93 (+2.70%)
MU   67.54 (-0.34%)
CGC   0.74 (-5.13%)
GE   105.46 (+1.31%)
DIS   92.16 (+1.27%)
AMC   4.64 (+0.22%)
PFE   38.37 (-0.72%)
PYPL   65.02 (+0.79%)
NFLX   399.29 (-1.05%)
QQQ   354.84 (-0.02%)
AAPL   179.21 (-0.21%)
MSFT   333.68 (-0.67%)
META   271.12 (-0.10%)
GOOGL   127.31 (+1.03%)
AMZN   126.61 (+1.05%)
TSLA   221.31 (+1.70%)
NVDA   386.54 (-1.32%)
NIO   7.87 (+2.61%)
BABA   86.69 (+2.71%)
AMD   124.23 (+5.34%)
T   15.66 (+1.75%)
F   12.93 (+2.70%)
MU   67.54 (-0.34%)
CGC   0.74 (-5.13%)
GE   105.46 (+1.31%)
DIS   92.16 (+1.27%)
AMC   4.64 (+0.22%)
PFE   38.37 (-0.72%)
PYPL   65.02 (+0.79%)
NFLX   399.29 (-1.05%)
QQQ   354.84 (-0.02%)
AAPL   179.21 (-0.21%)
MSFT   333.68 (-0.67%)
META   271.12 (-0.10%)
GOOGL   127.31 (+1.03%)
AMZN   126.61 (+1.05%)
TSLA   221.31 (+1.70%)
NVDA   386.54 (-1.32%)
NIO   7.87 (+2.61%)
BABA   86.69 (+2.71%)
AMD   124.23 (+5.34%)
T   15.66 (+1.75%)
F   12.93 (+2.70%)
MU   67.54 (-0.34%)
CGC   0.74 (-5.13%)
GE   105.46 (+1.31%)
DIS   92.16 (+1.27%)
AMC   4.64 (+0.22%)
PFE   38.37 (-0.72%)
PYPL   65.02 (+0.79%)
NFLX   399.29 (-1.05%)
QQQ   354.84 (-0.02%)
AAPL   179.21 (-0.21%)
MSFT   333.68 (-0.67%)
META   271.12 (-0.10%)
GOOGL   127.31 (+1.03%)
AMZN   126.61 (+1.05%)
TSLA   221.31 (+1.70%)
NVDA   386.54 (-1.32%)
NIO   7.87 (+2.61%)
BABA   86.69 (+2.71%)
AMD   124.23 (+5.34%)
T   15.66 (+1.75%)
F   12.93 (+2.70%)
MU   67.54 (-0.34%)
CGC   0.74 (-5.13%)
GE   105.46 (+1.31%)
DIS   92.16 (+1.27%)
AMC   4.64 (+0.22%)
PFE   38.37 (-0.72%)
PYPL   65.02 (+0.79%)
NFLX   399.29 (-1.05%)
NASDAQ:KZR

Kezar Life Sciences (KZR) Earnings Date, Estimates & Call Transcripts

$3.06
+0.15 (+5.15%)
(As of 06/6/2023 ET)
Compare
Today's Range
$2.83
▼
$3.08
50-Day Range
$2.34
▼
$3.23
52-Week Range
$2.25
▼
$11.02
Volume
489,852 shs
Average Volume
872,490 shs
Market Capitalization
$221.57 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$17.33
ProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial MediaSustainability

Earnings Summary

Upcoming
Earnings Date
Aug. 10Estimated
Actual EPS
(Mar. 14)
-$0.25 Missed By -$0.01
Consensus EPS
(Mar. 14)
-$0.24
Last Year's Q1 EPS
(3/17/2022)
-$0.25
Skip Charts & View Estimated and Actual Earnings Data
Earnings Per ShareRevenue

KZR Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

KZR Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Kezar Life Sciences Analyst Forecasts

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20233($0.30)($0.26)($0.28)
Q2 20233($0.31)($0.28)($0.30)
Q3 20233($0.33)($0.28)($0.30)
Q4 20233($0.35)($0.28)($0.31)
FY 202312($1.29)($1.10)($1.19)
Q1 20241($0.29)($0.29)($0.29)
Q2 20241($0.31)($0.31)($0.31)
Q3 20241($0.31)($0.31)($0.31)
Q4 20241($0.31)($0.31)($0.31)
FY 20244($1.22)($1.22)($1.22)

KZR Earnings Date and Information

Kezar Life Sciences last posted its earnings data on March 14th, 2023. The reported ($0.25) earnings per share for the quarter, missing the consensus estimate of ($0.24) by $0.01. Kezar Life Sciences has generated ($1.06) earnings per share over the last year (($1.06) diluted earnings per share). Earnings for Kezar Life Sciences are expected to decrease in the coming year, from ($1.31) to ($1.39) per share. Kezar Life Sciences has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, August 10th, 2023 based off prior year's report dates.

Kezar Life Sciences Earnings History by Quarter

Export to Excel
DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
8/10/2023
(Estimated)		        
5/11/2023Q1 2023($0.28)($0.31)($0.03)($0.31)
3/14/2023Q4 2022($0.24)($0.25)($0.01)($0.25)
11/10/2022Q3 2022($0.26)($0.25)+$0.01($0.25)
8/11/2022Q2 2022($0.27)($0.25)+$0.02($0.25)
5/12/2022Q1 2022($0.29)($0.26)+$0.03($0.26)    
3/17/2022Q4 2021($0.29)($0.25)+$0.04($0.25)
11/9/20219/30/2021($0.26)($0.28)($0.02)($0.28)
8/12/20216/30/2021($0.26)($0.25)+$0.01($0.25)
5/12/20213/31/2021($0.24)($0.25)($0.01)($0.25)
3/11/202112/31/2020($0.23)($0.22)+$0.01($0.22)
11/5/2020Q3 2020($0.21)($0.23)($0.02)($0.23)  
8/5/2020Q2 2020($0.26)($0.22)+$0.04($0.22)  
5/7/2020Q1 2020($0.3740)($0.30)+$0.0740($0.30)
3/12/2020Q4 2019($0.5450)($0.5009)+$0.0441($0.50)
11/6/2019Q3($0.5140)($0.48)+$0.0340($0.48)
8/7/2019Q2 2019($0.4760)($0.46)+$0.0160($0.46)
5/7/2019Q1 2019($0.40)($0.40)($0.40)
3/26/201912/31/2018($0.36)($0.30)+$0.06($0.30)
11/8/20189/30/2018($0.48)($0.30)+$0.18($0.30)
8/9/2018Q2 2018($0.5430)($3.31)($2.7670)($3.31)












Kezar Life Sciences Earnings - Frequently Asked Questions

When is Kezar Life Sciences's earnings date?

Kezar Life Sciences has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, August 10th, 2023 based off last year's report dates. Learn more on KZR's earnings history.

Did Kezar Life Sciences beat their earnings estimates last quarter?

In the previous quarter, Kezar Life Sciences (NASDAQ:KZR) missed the analysts' consensus estimate of ($0.24) by $0.01 with a reported earnings per share (EPS) of ($0.25). Learn more on analysts' earnings estimate vs. KZR's actual earnings.

How much profit does Kezar Life Sciences generate each year?

Kezar Life Sciences (NASDAQ:KZR) has a recorded net income of -$68.24 million. KZR has generated -$1.06 earnings per share over the last four quarters.

What is Kezar Life Sciences's EPS forecast for next year?

Kezar Life Sciences's earnings are expected to decrease from ($1.31) per share to ($1.39) per share in the next year.

More Earnings Resources from MarketBeat

Related Companies:
Earnings Tools:
Earnings By Country:
Latest Articles:
This page (NASDAQ:KZR) was last updated on 6/6/2023 by MarketBeat.com Staff

My Account -